ArticleCell death discovery2023

Blocking the CXCL1-CXCR2 axis enhances the effects of doxorubicin in HCC by remodelling the tumour microenvironment via the NF-κB/IL-1β/CXCL1 signalling pathway.

Huiyong Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.